These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18374571)

  • 41. Accurate Prediction of Ligand Affinities for a Proton-Dependent Oligopeptide Transporter.
    Samsudin F; Parker JL; Sansom MSP; Newstead S; Fowler PW
    Cell Chem Biol; 2016 Feb; 23(2):299-309. PubMed ID: 27028887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1.
    Geissler S; Hellwig M; Zwarg M; Markwardt F; Henle T; Brandsch M
    J Agric Food Chem; 2010 Feb; 58(4):2543-7. PubMed ID: 20104847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions.
    Nielsen CU; Brodin B
    Curr Drug Targets; 2003 Jul; 4(5):373-88. PubMed ID: 12816347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the human peptide transporter PEPT1 promoter: Sp1 functions as a basal transcriptional regulator of human PEPT1.
    Shimakura J; Terada T; Katsura T; Inui K
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G471-7. PubMed ID: 15905415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1.
    Uchiyama T; Kulkarni AA; Davies DL; Lee VH
    Pharm Res; 2003 Dec; 20(12):1911-6. PubMed ID: 14725353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.
    Terada T; Sawada K; Irie M; Saito H; Hashimoto Y; Inui K
    Pflugers Arch; 2000 Sep; 440(5):679-84. PubMed ID: 11007306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct evidence for efficient transport and minimal metabolism of L-cephalexin by oligopeptide transporter 1 in budded baculovirus fraction.
    Mitsuoka K; Tamai I; Morohashi Y; Kubo Y; Saitoh R; Tsuji A; Kato Y
    Biol Pharm Bull; 2009 Aug; 32(8):1459-61. PubMed ID: 19652390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cloning and characterization of a pH-sensing regulatory factor that modulates transport activity of the human H+/peptide cotransporter, PEPT1.
    Saito H; Motohashi H; Mukai M; Inui K
    Biochem Biophys Res Commun; 1997 Aug; 237(3):577-82. PubMed ID: 9299407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delineation of human peptide transporter 1 (hPepT1)-mediated uptake and transport of substrates with varying transporter affinities utilizing stably transfected hPepT1/Madin-Darby canine kidney clones and Caco-2 cells.
    Bhardwaj RK; Herrera-Ruiz D; Sinko PJ; Gudmundsson OS; Knipp G
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1093-100. PubMed ID: 15901802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist.
    Surendran N; Covitz KM; Han H; Sadee W; Oh DM; Amidon GL; Williamson RM; Bigge CF; Stewart BH
    Pharm Res; 1999 Mar; 16(3):391-5. PubMed ID: 10213369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
    Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
    ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter.
    Chu XY; Sánchez-Castaño GP; Higaki K; Oh DM; Hsu CP; Amidon GL
    J Pharmacol Exp Ther; 2001 Nov; 299(2):575-82. PubMed ID: 11602669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peptide derivation of poorly absorbable drug allows intestinal absorption via peptide transporter.
    Kikuchi A; Tomoyasu T; Tanaka M; Kanamitsu K; Sasabe H; Maeda T; Odomi M; Tamai I
    J Pharm Sci; 2009 May; 98(5):1775-87. PubMed ID: 18781650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells.
    Vavricka SR; Musch MW; Chang JE; Nakagawa Y; Phanvijhitsiri K; Waypa TS; Merlin D; Schneewind O; Chang EB
    Gastroenterology; 2004 Nov; 127(5):1401-9. PubMed ID: 15521010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A charge pair interaction between Arg282 in transmembrane segment 7 and Asp341 in transmembrane segment 8 of hPepT1.
    Kulkarni AA; Davies DL; Links JS; Patel LN; Lee VH; Haworth IS
    Pharm Res; 2007 Jan; 24(1):66-72. PubMed ID: 17009102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules.
    Merlin D; Si-Tahar M; Sitaraman SV; Eastburn K; Williams I; Liu X; Hediger MA; Madara JL
    Gastroenterology; 2001 Jun; 120(7):1666-79. PubMed ID: 11375948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. hPepT1-mediated epithelial transport of bacteria-derived chemotactic peptides enhances neutrophil-epithelial interactions.
    Merlin D; Steel A; Gewirtz AT; Si-Tahar M; Hediger MA; Madara JL
    J Clin Invest; 1998 Dec; 102(11):2011-8. PubMed ID: 9835627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prodrug design targeting intestinal PepT1 for improved oral absorption: design and performance.
    Zhang Y; Sun J; Sun Y; Wang Y; He Z
    Curr Drug Metab; 2013 Jul; 14(6):675-87. PubMed ID: 23869811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The tandem chain extension aldol reaction used for synthesis of ketomethylene tripeptidomimetics targeting hPEPT1.
    Thorn K; Nielsen CU; Jakobsen P; Steffansen B; Zercher CK; Begtrup M
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4597-601. PubMed ID: 21703856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced absorption and growth inhibition with amino acid monoester prodrugs of floxuridine by targeting hPEPT1 transporters.
    Tsume Y; Vig BS; Sun J; Landowski CP; Hilfinger JM; Ramachandran C; Amidon GL
    Molecules; 2008 Jun; 13(7):1441-54. PubMed ID: 18719516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.